THE ALBERTA GAZETTE, PART II, AUGUST 15, Alberta Regulation 155/2002. Cancer Programs Act CANCER PROGRAMS AMENDMENT REGULATION SCHEDULE

Transcription

1 Alberta Regulation 155/2002 Cancer Programs Act CANCER PROGRAMS AMENDMENT REGULATION Filed: July 18, 2002 Made by the Minister of Health and Wellness (M.O. 65/2002) on July 16, 2002 pursuant to sections 16 and 22 of the Cancer Programs Act. 1 The Cancer Programs Regulation (AR 242/98) is amended by this Regulation. 2 The Schedule is repealed and the following is substituted: SCHEDULE Drug Grou Dosage Criteria p Form 13 Cis-RETINOIC ACID 2 capsules Pediatrics restricted to the treatment of advanced stage neuroblastoma following POG/CCG Protocols the pediatric tumour program ALL-TRANS RETINOIC ACID 2 capsules restricted to treatment of acute promyelocytic leukemia the hematology/lymphoma tumour program or the pediatric tumour program AMSACRINE 2 injectable ANAGRELIDE 1 capsules for thrombocytosis due to myeloproliferative disorder the hematology/lymphoma tumour program

2 ALTA. REG. 155/2002 CANCER PROGRAMS Drug Grou Dosage Criteria p Form ANASTROZOLE 1 tablets alternative first line hormonal therapy for post menopausal women with hormone positive, metastatic breast cancer ASPARAGINASE 2 injectable BCG 1 injectable bladder carcinoma BICALUTAMIDE 1 tablets restricted to patients who are intolerant to Nilutamide or Flutamide. approved dosage is 50 mg daily. BLEOMYCIN 1 injectable 2 pump BUSERELIN 1 injectable prostate cancer Restricted to: Stage II (T2a-T2c): Neoadjuvant use pre RT (2 months pre and during RT). Neoadjuvant use pre radical prostatectomy (4 months pre). Stage III (T3a-T4b): Neoadjuvant use pre RT (2 months pre and during RT). Adjuvant use (3 years post RT). Stage IV (N1-N3) (M1-M1c): As monotherpy in medical castration. In total androgen blockade (medical castration and nonsteriodal antiandrogen). Guidelines for LHRH use in the above stated stages include: LHRH agonists are indicated for use in patients at risk of thromboembolic disease, strokes (CVA), myocardial infarction and also for consideration in patients with dyslipidemia, hypertension, diabetes mellitus or where a patient is considered intolerant to cyproterone acetate or megestrol acetate

3 ALTA. REG. 155/2002 CANCER PROGRAMS Drug Grou Dosage Criteria p Form BUSULFAN 1 tablets CAPECITABINE 2 oral for use in anthracycline 2 oral pretreated metastatic or advanced breast cancer patients who may or may not have been previously treated with taxanes. the breast tumour program option in first line treatment of advanced or metastatic colorectal cancer named physicians as recommended by the GI tumour program CARBOPLATIN 1 injectable CARMUSTINE 1 injectable CHLORAMBUCIL 1 tablets CISPLATIN 1 injectable CLADRIBINE 2 injectable restricted to treatment of hairy cell leukemia Waldenstrom s macroglobulinemia the hematology/lymphoma tumour program 3 injectable POG Protocol 9720 the pediatric tumour program CLODRONATE 1 oral treatment of osteolytic bone lesions in metastatic breast cancer CYCLOPHOSPHAMIDE 1 injectable, tablets

4 ALTA. REG. 155/2002 CANCER PROGRAMS Drug Grou Dosage Criteria p Form CYPROTERONE 1 tablets CYTARABINE 1 injectable CYTARABINE LIPOSOMAL 2 injectable for intrathecal management of neoplastic meningitis due to solid tumours or lymphoma DACARBAZINE 1 injectable DACTINOMYCIN 1 injectable DAUNORUBICIN 1 injectable DEXAMETHASONE 1 injectable, antiemetic use NOT tablets covered DOCETAXEL 2 injectable treatment of metastatic breast cancer after failure of any previous chemotherapy regimen. as a single agent or in combination, as an option for first line treatment of metastatic breast cancer only one taxane is to be administered to any one patient named physicians as recommended by the breast tumour program DOXORUBICIN 1 injectable 2 injectable 2nd line therapy in patients with advanced or metastatic non-small cell lung cancer having received prior platinum-based chemotherapy, good performance status (ECOG 0-2), no brain metastases named physicians as recommended by the lung tumour program

5 ALTA. REG. 155/2002 CANCER PROGRAMS Drug Grou Dosage Criteria p Form DOXORUBICIN LIPOSOMAL 2 injectable Kaposi s sarcoma 2 injectable 2nd or 3rd line treatment of ovarian cancer, fallopian tube carcinoma and primary peritoneal neoplasms named physicians as recommended by the gynecology tumour program EPIRUBICIN 2 injectable adjuvant (node positive) and neoadjuvant (stage II and III), treatment of pre and post menopausal breast cancer patients named physicians as recommended by the breast tumour program ERWINIA ASPARAGINASE 3 injectable restricted to use in patients hypersensitive to E. Coli asparaginase for remission induction in acute lymphoblastic leukemia the pediatric tumour program or the hematology/ lymphoma program ESTRAMUSTINE 1 capsules ETOPOSIDE 1 injectable, capsules EXEMESTANE 2 oral for hormonal treatment of advanced breast cancer in postmenopausal women who have progressed following hormonal therapy named physicians as recommended by the breast tumour program

6 ALTA. REG. 155/2002 CANCER PROGRAMS Drug Grou Dosage Criteria p Form FLUDARABINE 2 injectable previously treated or untreated chronic lymphocytic leukemia low grade lymphoma Waldenstrom s macroglobulinemia the hematology/lymphoma tumour program FLUOROURACIL 1 injectable, cream 2 pump FLUTAMIDE 1 tablets prostate cancer GEMCITABINE 2 injectable Lung Cancer patients who have failed treatment with Vinorelbine or Paclitaxel containing regimens or who are unable to tolerate treatment with these agents. the lung tumour program 2 injectable Bladder Cancer Gemcitabine/Cisplatin as first line chemotherapy in locally advanced/metastatic bladder cancer the GU tumour program 2 injectable Pancreas locally advanced or metastatic adenocarcinoma of the pancreas. the GI tumour program

7 ALTA. REG. 155/2002 CANCER PROGRAMS Drug Grou Dosage Criteria p Form GOSERELIN 1 injectable prostate cancer Restricted to: Stage II (T2a-T2c): Neoadjuvant use pre RT (2 months pre and during RT). Neoadjuvant use pre radical prostatectomy (4 months pre). Stage III (T3a-T4b): Neoadjuvant use pre RT (2 months pre and during RT). Adjuvant use (3 years post RT). Stage IV (N1-N3) (M1-M1c): As monotherpy in medical castration. In total androgen blockade (medical castration and nonsteriodal antiandrogen). Guidelines for LHRH use in the above stated stages include: LHRH agonists are indicated for use in patients at risk of thromboembolic disease, strokes (CVA), myocardial infarction and also for consideration in patients with dyslipidemia, hypertension, diabetes mellitus or where a patient is considered intolerant to cyproterone acetate or megestrol acetate. 2 injectable breast cancer. 2nd line hormonal therapy for recurrent or metastatic disease in estrogen and/or progesterone receptor positive pre and perimenopausal patients after tamoxifen failure. the breast tumour program HYDROCORTISONE SODIUM SUCCINATE 1 injectable intrathecal use only HYDROXYUREA 1 capsules

8 ALTA. REG. 155/2002 CANCER PROGRAMS Drug Grou Dosage Criteria p Form IDARUBICIN 3 injectable POG Protocol 9720 the pediatric tumour program IFOSFAMIDE 1 injectable 2 pump INTERFERON 1 injectable cladribine-resistant hairy - alpha 2a or 2b cell leukemia Kaposi s sarcoma chronic myelogenous - alpha 2b in new patients leukemia metastatic renal cell carcinoma INTERFERON 1 injectable mycosis fungoides and alpha 2a ONLY sezary syndrome (cutaneous T-cell lymphomas) the hematology/lymphoma tumour program INTERFERON 1 injectable basal cell carcinoma alpha 2b ONLY adjuvant treatment of high risk melanoma 2nd line therapy of superficial bladder cancer 2 injectable treatment of patients with malignant carcinoid and neuroendocrine gastroenteropancreatic tumours not amenable to surgical extirpation the GI and endocrine tumour programs

9 ALTA. REG. 155/2002 CANCER PROGRAMS Drug Grou Dosage Criteria p Form 2 injectable maintenance therapy in multiple myeloma patients who have achieved complete remission after high dose chemotherapy and autologous stem cell transplant. follicular lymphoma and need for therapy as indicated by any of: mass >7 cm or 3 sites >3 cm, Bsx, umbilicus, compression syndromes (GI, GU, orbit), effusions cytopenias, Age < 70 yo the hematology/lymphoma tumour program. IRINOTECAN 2 injectable Metastatic Colorectal Cancer first line (with 5FU and * NOTE: leucovorin). Loperamide supplied by industry 2nd line after 5FU based with this agent s use chemo. the GI tumour program. Pediatrics 2 injectable restricted to the treatment of high risk metastatic rhabdomyosarcomas following POG/CCG protocols the pediatric tumour program

10 ALTA. REG. 155/2002 CANCER PROGRAMS Drug Grou Dosage Criteria p Form LETROZOLE 1 tablets 2nd line hormonal therapy for postmenopausal metastatic breast cancer may be given first line in those patients with metastatic hormone receptor positive postmenopausal disease who are at risk of a thromboembolic event (history of previous thromboembolic event). LEUCOVORIN CALCIUM 1 injectable, rescue therapy for tablets methotrexate only in combination with 5FU LEUPROLIDE 1 injectable prostate cancer Restricted to: Stage II (T2a-T2c): Neoadjuvant use pre RT (2 months pre and during RT). Neoadjuvant use pre radical prostatectomy (4 months pre). Stage III (T3a-T4b): Neoadjuvant use pre RT (2 months pre and during RT). Adjuvant use (3 years post RT). Stage IV (N1-N3) (M1-M1c): As monotherpy in medical castration. In total androgen blockade (medical castration and nonsteriodal antiandrogen). LOMUSTINE 1 capsules Guidelines for LHRH use in the above stated stages include: LHRH agonists are indicated for use in patients at risk of thromboembolic disease, strokes (CVA), myocardial infarction and also for consideration in patients with dyslipidemia, hypertension, diabetes mellitus or where a patient is considered intolerant to cyproterone acetate or megestrol acetate

11 ALTA. REG. 155/2002 CANCER PROGRAMS Drug Grou Dosage Criteria p Form MECHLORETHAMINE 1 injectable, topical MEDROXYPROGESTERONE 1 tablets, ACETATE injectable MEGESTROL ACETATE 1 tablets MELPHALAN 1 tablets MERCAPTOPURINE 1 tablets MESNA 1 injectable METHOTREXATE 1 injectable, tablets MITOMYCIN 1 injectable NOTE: 3rd line for bladder cancer indication MITOXANTRONE 1 injectable NANDROLONE DECANOATE 1 injectable NILUTAMIDE 1 tablets prostate cancer PACLITAXEL 2 injectable Ovarian Cancer first line treatment of ovarian cancer (irrespective of the stage of disease or amount of residual disease), fallopian tube carcinoma, primary peritoneal neoplasms, and papillary serous and clear cell endometrial carcinomas the gynecology tumour program 2 injectable Lung Cancer the lung tumour program

12 ALTA. REG. 155/2002 CANCER PROGRAMS Drug Grou Dosage Criteria p Form 2 injectable Breast Cancer restricted to the treatment of metastatic breast cancer when no response to anthracycline (doxorubicin, epirubicin, or mitoxantrone) containing regimen. Relapse within 1 year after completion of adjuvant chemotherapy including an anthracycline. First assessment of efficacy after 2 courses only one taxane is to be administered to any one patient the breast tumour program 2 injectable Endometrial Cancer restricted for use in metastatic, advanced or recurrent endometrial cancer named physicians as recommended by the gynecology tumour program 2 injectable Testes 2nd line regimen for relapsed germ cell tumours of the testes 2 injectable in combination chemotherapy for unknown primary metastatic adenocarcinoma named physicians as recommended by the breast and hematology tumour programs PAMIDRONATE 1 injectable treatment of multiple myeloma

13 ALTA. REG. 155/2002 CANCER PROGRAMS Drug Grou Dosage Criteria p Form PEG ASPARAGINASE 3 injectable the pediatric tumour program as per POG protocols PREDNISOLONE SODIUM 1 liquid first line agent for pediatric PHOSPHATE patients under 7 years of age 2nd-line agent for pediatric patients 7 years and older unable to tolerate prednisone tablets PREDNISONE 1 tablets PROCARBAZINE 1 capsules RALTITREXED 2 injectable treatment of metastatic colorectal cancer NOTE: Because there is a possibility that FUFA may provide slightly superior survival, FUFA should remain the first choice for younger, fitter patients. Raltitrexed may be considered the treatment of choice in elderly patients (over age 70), patients who have experienced severe mucositis with FUFA despite one stage of dose reduction, or in patients with late relapse after adjuvant treatment where the adjuvant 5FU based treatment was poorly tolerated with documented reason for intolerance. the GI tumour program RITAXIMAB 2 injectable relapsed or refractory follicular lymphoma the lymphoma tumour program

14 ALTA. REG. 155/2002 CANCER PROGRAMS Drug Grou Dosage Criteria p Form STREPTOZOCIN 1 injectable TAMOXIFEN 1 tablets 2 injectable in combination with CHOP for aggressive histology B-cell CD20 positive non-hodgkin s lymphoma in patients 60 years of age or older named physicians as recommended by the hematology/lymphoma tumour program TEMOZOLOMIDE 2 oral first-line treatment of recurrent glioblastoma multiforme and anaplastic astrocytoma the neuro oncology tumour program TENIPOSIDE 1 injectable THALIDOMIDE 3 oral in refractory multiple myeloma Special Access Program, Health Protection Branch named physicians as recommended by the lymphoma tumour program THIOGUANINE 1 tablets THIOTEPA 2 injectable

15 ALTA. REG. 155/2002 CANCER PROGRAMS Drug Grou Dosage Criteria p Form TOPOTECAN 2 injectable Ovarian advanced epithelial ovarian cancer as 2nd line therapy the gynecology tumour program Pediatrics restricted to the treatment of advanced stage neuroblastoma following POG/CCG Protocols restricted to the treatment of intermediate risk rhabdomyosarcoma following POG/CCG protocols the pediatric tumour program TRASTUZUMAB 2 injectable Metastatic Breast restricted to the treatment of metastatic breast cancer, HER 2 protein overexpression (+3) the breast tumour program VINBLASTINE 1 injectable VINCRISTINE 1 injectable VINORELBINE 2 injectable Lung Cancer restricted to the treatment of metastatic non-small cell lung cancer with an ECOG score of 2 or better. the lung tumour program

16 ALTA. REG. 155/2002 CANCER PROGRAMS Drug Grou Dosage Criteria p Form 2 injectable Metastatic Breast first line therapy for elderly patients (over 65 years of age) and 2nd or 3rd line therapy for metastatic breast cancer. Assess response after 2 cycles. the breast tumour program Alberta Regulation 156/2002 Safety Codes Act BOILERS AND PRESSURE VESSELS EXEMPTION AMENDMENT ORDER Filed: July 22, 2002 Made by the Minister of Municipal Affairs (M.O. P:004/02) on July 13, 2002 pursuant to section 2(2) of the Safety Codes Act. 1 The Boilers and Pressure Vessels Exemption Order (AR 300/94) is amended by this Order. 2 The following is added after section 3: Expiry 3.1 For the purpose of ensuring that this Order is reviewed for ongoing relevancy and necessity, with the option that it may be repassed in its present or an amended form following a review, this Order expires on March 31,

17 Alberta Regulation 157/2002 Safety Codes Act BOILERS AND PRESSURE VESSELS AMENDMENT REGULATION Filed: July 23, 2002 Made by the Lieutenant Governor in Council (O.C. 349/2002) on July 23, 2002 pursuant to section 65 of the Safety Codes Act. 1 The Boilers and Pressure Vessels Regulation (AR 293/94) is amended by this Regulation. 2 The heading COMMENCEMENT preceding section 10 is repealed and the heading EXPIRY AND COMING INTO FORCE is substituted. 3 The following is added before section 10: Expiry 9.1 For the purpose of ensuring that this Regulation is reviewed for ongoing relevancy and necessity, with the option that it may be repassed in its present or an amended form following a review, this Regulation expires on March 31, Alberta Regulation 158/2002 Safety Codes Act DESIGN, CONSTRUCTION AND INSTALLATION OF BOILERS AND PRESSURE VESSELS AMENDMENT REGULATION Filed: July 23, 2002 Made by the Lieutenant Governor in Council (O.C. 350/2002) on July 23, 2002 pursuant to section 65 of the Safety Codes Act. 1 The Design, Construction and Installation of Boilers and Pressure Vessels Regulations (AR 227/75) are amended by this Regulation. 2 Section 1 is amended (a) in clause (a) by striking out Boilers and Pressure Vessels Act and substituting Safety Codes Act ; (b) by repealing clauses (e), (g) and (g.1)

18 ALTA. REG. 158/2002 SAFETY CODES 3 Section 2 is amended (a) in subsection (1) by striking out the words preceding clause (a) and substituting the following: 2(1) The following are exempt from this Regulation and the Boilers and Pressure Vessels Regulation (AR 293/94): (b) in subsection (2) by striking out a certificate of inspection under section 18(3) of the Act and substituting an inspection/certification permit under section 6 of the Boilers and Pressure Vessels Regulation (AR 293/94). 4 Section 3(1) is amended by striking out 5, 6 and 18(1)(a) of the Act and substituting 4 and 5 of the Boilers and Pressure Vessels Regulation (AR 293/94). 5 Section 4 is amended (a) in subsection (1) by striking out the words preceding clause (a) and substituting the following: 4(1) Pressure equipment that contains or is intended to contain an expansible fluid under pressure, has a capacity of m 3 or less and is of a type or class listed below is subject to sections 4 and 5 of the Boilers and Pressure Vessels Regulation (AR 293/94) as if it is a pressure vessel as defined in that Regulation: (b) by repealing subsection (2) and substituting the following: (2) Pressure equipment that contains or is intended to contain an 3 expansible fluid under pressure, has a capacity of m or less, and that is not of a type or class listed in subsection (1) is subject to sections 4 and 5 of the Boilers and Pressure Vessels Regulation (AR 293/94) as if it is a fitting as defined in that Regulation. 6 Section 6(1) is amended by striking out In accordance with section 5 of the Act, where and substituting Where. 7 Section 7(1) is amended by striking out In accordance with section 5 of the Act, where and substituting Where. 8 Section 9 is amended by striking out In accordance with section 6 of the Act, any and substituting Any

19 ALTA. REG. 158/2002 SAFETY CODES 9 Section 11(1) is amended by striking out In accordance with section 7 of the Act, where and substituting Where. 10 The following are repealed: Part 4; section 33.1(3); section 38; section 39; section 43(7) and (8); section 55; section 55.1; section Section 47.1 is amended (a) in subsection (1) by repealing clause (a) and substituting the following: (a) authority having jurisdiction has the same meaning as declared in force by the Fire in Code the Alberta Regulation Fire Code (AR 52/98); 1997, (b) in subsection (2) by striking out fire authority for approval by the fire authority and substituting authority having jurisdiction for approval. 12 Section 60 is amended by striking out Fire Prevention Act and substituting Act. 13 The following is added after section 61: Expiry 62 For the purpose of ensuring that this Regulation is reviewed for ongoing relevancy and necessity, with the option that it may be repassed in its present or an amended form following a review, this Regulation expires on March 31,

20 Alberta Regulation 159/2002 Safety Codes Act PLUMBING CODE AMENDMENT REGULATION Filed: July 23, 2002 Made by the Lieutenant Governor in Council (O.C. 351/2002) on July 23, 2002 pursuant to section 65 of the Safety Codes Act. 1 The Plumbing Code Regulation (AR 219/97) is amended by this Regulation. 2 Section 1(1) is amended by adding the following after clause (a): (a.1) certification body means an organization accredited or recognized by the Standards Council of Canada as a certification body; 3 Section 2(1) is amended (a) in clauses (a) and (b) by striking out organization accredited by the Standards Council of Canada and substituting body ; (b) in clause (b) by striking out the certification organization and substituting the certification body. 4 Section 3(3) is amended by striking out 1990 and substituting Sections 4 and 5 are repealed and the following is substituted: Effect of codes 4 The Code referred to in, and as varied by, section 3, and any codes or standards referenced in that Code, do not make or imply any assurance or guarantee by the Crown in right of Alberta with respect to the life expectancy, durability or operating performance of equipment or materials referenced in the codes or standards

21 Alberta Regulation 160/2002 Government Organization Act RADIATION HEALTH ADMINISTRATION AMENDMENT REGULATION Filed: July 23, 2002 Made by the Lieutenant Governor in Council (O.C. 352/2002) on July 23, 2002 pursuant to Schedule 10, section 2 of the Government Organization Act. 1 The Radiation Heath Administration Regulation (AR 49/96) is amended by this Regulation. 2 Section 2 is amended (a) in subsection (1) by striking out (4), (6) and (8) and substituting (5), (7) and (9) ; (b) in subsection (3) by striking out section 10(7) and substituting section 10(8) ; (c) in subsection (6) by striking out section 16(2) and substituting section 16(3). 3 Section 7(1) is amended by striking out (Alta. Reg. 57/95) wherever it occurs and substituting (AR 224/2001). 4 Schedules 1 and 2 are repealed and the attached Schedules 1 and 2 are substituted. SCHEDULE 1 (Organizations) ROW COLUMN 1 COLUMN 2 COLUMN 3 1 College of Therapeutic or diagnostic Installed or Physicians and x-ray equipment; operated within Surgeons of Therapy simulator private and public Alberta equipment; medical facilities, Cabinet x-ray equipment; public dental Class 3b and 4 lasers; facilities, medical Particle accelerators; education facilities Diffraction and analysis and podiatry x-ray equipment facilities

22 ALTA. REG. 160/2002 GOVERNMENT ORGANIZATION ROW COLUMN 1 COLUMN 2 COLUMN 3 2 Alberta Dental Diagnostic x-ray Installed or Association equipment; operated within Class 3b and 4 lasers dental facilities, including dental education facilities, but excluding dental facilities owned by a Regional Health Authority 3 University of Cabinet x-ray equipment; Installed or Calgary Class 3B and 4 lasers; operated within Diffraction and analysis non-medical x-ray equipment; facilities owned or Industrial radiographic and operated by the fluoroscopic x-ray University of equipment; Calgary and Irradiation x-ray research, equipment; education, Particle accelerators; industrial, Therapeutic or diagnostic commercial, x-ray equipment; entertainment and Computed tomography other health related equipment; facilities Baggage inspection x-ray equipment; Security x-ray equipment 4 College of Diagnostic x-ray Installed or Chiropractors equipment; operated within of Alberta Class 3b and 4 lasers chiropractic facilities 5 Alberta Diagnostic x-ray Installed or Veterinary equipment; operated within Medical Class 3b and 4 lasers veterinary clinics Association and veterinary education facilities 6 University of Cabinet x-ray equipment; Installed or Alberta Class 3b and 4 lasers; operated within Diffraction and analysis non-medical x-ray equipment; facilities owned or Therapeutic or diagnostic operated by the x-ray equipment; University of Particle accelerators Alberta

23 ALTA. REG. 160/2002 GOVERNMENT ORGANIZATION SCHEDULE 2 (Agencies) ROW COLUMN 1 COLUMN 2 COLUMN 3 1 Alberta Diagnostic or therapeutic Installed or Radiation x-ray equipment; Class 3b operated within Service and 4 lasers dental, medical, Box 1533 chiropractic, Cardston, AB T0K 0K0 veterinary, physical therapy, education, industrial, commercial, research and entertainment facilities 2 RadMan Diagnostic or therapeutic Installed or Radiation x-ray equipment; operated within Management Cabinet x-ray equipment; dental, medical, Services Ltd. Class 3b and 4 lasers chiropractic, 4536 Stanley veterinary, Drive SW physical therapy, Calgary, AB T2S 2R9 education, industrial, commercial, research and entertainment facilities 3 B&P Stewart Diagnostic or therapeutic Installed or Ent. Ltd. x-ray equipment operated within dental, medical, Range Rd 204 chiropractic, Sherwood veterinary and Park, AB education facilities T8G 1E9 4 University of Cabinet x-ray equipment; Installed or Calgary Diffraction and analysis operated within Safety x-ray equipment; education, Services Industrial radiographic and research and 2500 fluoroscopic x-ray veterinary facilities University equipment; owned or operated Drive NW Class 3b and 4 lasers; by the University Calgary, AB Diagnostic x-ray of Calgary T2N 1N4 equipment; Computed tomography equipment

24 ALTA. REG. 160/2002 GOVERNMENT ORGANIZATION ROW COLUMN 1 COLUMN 2 COLUMN 3 5 University of Diagnostic x-ray Installed or Alberta equipment; operated within Office of Cabinet x-ray equipment; education, Environmental Diffraction and analysis research, dental Health and x-ray equipment; and veterinary Safety Class 3b and 4 lasers; facilities owned or Edmonton, AB Particle accelerators operated by the T6G 2R5 University of Alberta 6 Calgary Health Diagnostic or therapeutic Installed or Region x-ray equipment; operated within Diagnostic Cabinet x-ray equipment; medical, dental Imaging Diffraction and analysis and physical Street x-ray equipment; therapy facilities NW Class 3b and 4 lasers; Calgary, AB Computed tomography T2N 2T9 equipment 7 Capital Health Diagnostic or therapeutic Installed or Authority x-ray equipment; operated within Imaging Cabinet x-ray equipment; medical, dental Services Diffraction and analysis and physical St x-ray equipment; therapy facilities Edmonton, AB Computed tomography T6G 2B7 equipment 8 David Diagnostic or therapeutic Installed or Thompson x-ray equipment operated within Regional medical and dental Health facilities owned or Authority operated by the Diagnostic David Thompson Imaging Regional Health A Authority Avenue Red Deer, AB T4N 4E7 9 Filipow Diagnostic or therapeutic Installed or Associates Inc. x-ray equipment; operated within Computed tomography medical, dental, Avenue equipment; chiropractic, Edmonton, AB Diffraction and analysis veterinary, T6A 1S2 x-ray equipment; education and Cabinet x-ray equipment; commercial Baggage inspection x-ray facilities equipment; Security x-ray equipment; Irradiation x-ray equipment

25 ALTA. REG. 160/2002 GOVERNMENT ORGANIZATION ROW COLUMN 1 COLUMN 2 COLUMN 3 10 Alberta Cancer Diagnostic or therapeutic Installed or Board x-ray equipment; operated within Provincial Therapy simulator x-ray medical, dental Radiation equipment; and research Safety Office Computed tomography facilities owned or Room 4027 equipment; operated by the Particle accelerators; Alberta Cancer University Cabinet x-ray equipment; Board Avenue Class 3b and 4 lasers Edmonton, AB T6G 1Z Alberta Regulation 161/2002 Victims of Crimes Act VICTIMS BENEFITS AMENDMENT REGULATION Filed: July 23, 2002 Made by the Lieutenant Governor in Council (O.C. 354/2002) on July 23, 2002 pursuant to section 17 of the Victims of Crimes Act. 1 The Victims Benefits Regulation (AR 201/97) is amended by this Regulation. 2 Section 8 is amended by striking out November 1, 2002 and substituting December 31, Alberta Regulation 162/2002 Victims of Crimes Act VICTIMS PROGRAMS AMENDMENT REGULATION Filed: July 23, 2002 Made by the Lieutenant Governor in Council (O.C. 355/2002) on July 23, 2002 pursuant to section 17 of the Victims of Crimes Act. 1 The Victims Programs Regulation (AR 135/97) is amended by this Regulation

26 ALTA. REG. 162/2002 VICTIMS OF CRIMES 2 Section 8 is amended by striking out August 1, 2002 and substituting December 31, Alberta Regulation 163/2002 Government Organization Act DESIGNATION AND TRANSFER OF RESPONSIBILITY AMENDMENT REGULATION Filed: July 23, 2002 Made by the Lieutenant Governor in Council (O.C. 356/2002) on July 23, 2002 pursuant to section 16 of the Government Organization Act. 1 The Designation and Transfer of Responsibility Regulation (AR 44/2001) is amended by this Regulation. 2 Section 5(5)(b) is repealed and the following is substituted: (b) in Schedule 3 of the Community Development Grants Regulation (AR 57/98) are transferred to the responsibility of the Minister of Gaming, and Alberta Regulation 164/2002 Alberta Treasury Branches Act ALBERTA TREASURY BRANCHES AMENDMENT REGULATION Filed: July 23, 2002 Made by the Lieutenant Governor in Council (O.C. 360/2002) on July 23, 2002 pursuant to section 34 of the Alberta Treasury Branches Act. 1 The Alberta Treasury Branches Regulation (AR 187/97) is amended by this Regulation. 2 Section 1(2) is amended (a) by repealing clause (c) and substituting the following: (c) financial leasing corporation means a corporation that enters into or acquires agreements as defined in section 5.1;

27 ALTA. REG. 164/2002 ALBERTA TREASURY BRANCHES (b) by repealing clause (d) and substituting the following: (d) information management corporation means a corporation whose activities are limited to (i) the collection, manipulation and transmission of information, (ii) the design, development, marketing and sale of computer software, (iii) the provision of advisory and other services related to the design and development of information management systems, (iv) the design, development, marketing and sale of equipment integral to information management systems, and (v) the design, development, management, manufacturing, marketing and sale of data transmission services, information sites, communication devices and information platforms or portals, in respect of information that is primarily financial or economic in nature or information that relates to the business of Alberta Treasury Branches or of a corporation in which Alberta Treasury Branches beneficially owns shares pursuant to section 19(4) of the Act; 3 The following is added after section 2: Prescribed corporation 2.1 A financial leasing corporation is a prescribed corporation for the purposes of section 19(4)(l) of the Act. 4 The following is added after section 5: Leasing and related agreements 5.1(1) In this section, (a) agreement means (i) a security agreement as defined in the Personal Property Security Act, or (ii) a financial lease agreement, being an agreement for a lease of personal property in which credit is extended by the lessor to the lessee for the purpose of enabling the lessee to meet the lessee s obligations under the lease;

28 ALTA. REG. 164/2002 ALBERTA TREASURY BRANCHES (b) property means the personal property to which an agreement relates. (2) Alberta Treasury Branches may not beneficially own shares in a financial leasing corporation unless (a) the aggregate of (i) the book value of all of the property that is subject to agreements held by the corporation, and (ii) all amounts owing as receivables in respect of such agreements is equal to at least 80% of the assets of the corporation, and (b) the corporation meets the requirements of the agreements. (3) A financial leasing corporation may enter into or acquire agreements only if the following requirements are met: (a) the corporation shall not direct its customers or potential customers to particular dealers in the property; (b) at no time may the aggregate of the estimated residual values of all the property of the corporation, excluding motor vehicles, leased under the financial lease agreements exceed 10% of the aggregate of the costs of acquisition of that leased property to the corporation; (c) the estimated residual value of property leased under a financial lease agreement must not exceed 20% of its cost of acquisition to the corporation; (d) the agreement must be entered into or acquired for the purpose of extending credit to the lessee or purchaser; (e) the property that is the subject of the agreement must be selected by the lessee or buyer and (i) must be acquired by the corporation at the request of the lessee or buyer, or (ii) must have been acquired by the corporation through the operation of an earlier agreement; (f) the agreement must yield a return that (i) will compensate the corporation for not less than its full investment in the property, (ii) is reasonable, taking into account

29 ALTA. REG. 164/2002 ALBERTA TREASURY BRANCHES (A) the term of agreement and the other terms and conditions of it, (B) the technological obsolescence of the property, and (C) the rate of return sought by the other lessors in respect of similar agreements in respect of similar property and under the same terms and conditions, and (iii) is calculated by taking into account (A) rental charges paid by the lessee or purchaser, (B) estimated tax benefits of the agreement to the corporation, including tax credits and capital cost allowance claims, and (C) the amount of, (I) where the lessee or purchaser or a third party who is dealing at arm s length with the corporation has, on or before the commencement of the agreement, contracted to purchase the property or unconditionally guaranteed the resale value of the property at the date of expiry of the agreement, the purchase price or the resale value so guaranteed, or (II) in any other case, but subject to clause (c), the estimated residual value of the property; (g) the agreement must contain a provision (i) assigning and conveying to the lessee or purchaser the benefit of all warranties, guarantees or other undertakings made by a manufacturer or supplier relating to property, or (ii) setting out the responsibilities of the corporation with regard to the warranties, guarantees or other undertakings referred to in subclause (i); (h) the agreement must substantially transfer to the lessee or purchaser the benefits and risks incidental to the operation of the property and must not place responsibility on the part of the corporation to install, promote, service, clean, maintain or repair the property;

30 ALTA. REG. 164/2002 ALBERTA TREASURY BRANCHES (i) where the lessee or purchaser defaults in the manner set out in the agreement and the default is not waived or the agreement, including any renewals or extensions of it, expires, the corporation shall (i) liquidate its interest in the property, or (ii) enter into a new agreement in respect of that property within 2 years of that default or expiry or, where proceedings in respect of that property have prevented the corporation from complying with that requirement within that period, within 2 years of the completion of those proceedings. (4) An agreement may be renewed on its expiry and may be extended during its terms. (5) The financial leasing corporation shall not enter into an agreement in respect of (a) a motor vehicle having a gross vehicle weight of less than 21 tonnes, or (b) personal household property. (6) For the purposes of subsection (5), (a) gross vehicle weight means, in respect of a motor vehicle, the gross vehicle weight that is specified by the manufacturer of the motor vehicle as the loaded weight of the motor vehicle, or in the case of a motor vehicle designed to pull a trailer, the motor vehicle with the trailer; (b) personal household property means personal property that is leased by an individual pursuant to a financial lease agreement or purchased by an individual pursuant to a conditional sales agreement and intended primarily for the personal use or enjoyment of the lessee or purchaser or of an individual who is not dealing at arm s length with the lessee or purchaser. 5 Section 8(5) is amended (a) by repealing clause (k) and substituting the following: (k) demand loans at book value, other than loans to an individual, that are fully secured by any of the following securities: (i) at market value, Treasury Bills of the Government of Canada or of a province;

31 ALTA. REG. 164/2002 ALBERTA TREASURY BRANCHES (ii) at book value, term deposits or other similar instruments issued by a financial institution that mature within 100 days after the applicable date; (iii) at market value, bankers acceptances that mature within one year from the date of issue and bearer deposit notes; (iv) at market value, commercial paper that matures within 90 days from the date of issue and has at least one of the short-term ratings referred to in the table in section 10(3); (v) at market value, securities, other than securities referred to in clause (i), that are issued or guaranteed by the Government of Canada, the government of a province or a municipality; (b) by adding the following after clause (k): (l) a line of credit to a participant in the Large Value Transfer System that has at least one of the commercial paper credit ratings referred to in the table in section 10(3). 6 The following is added after section 9.1: Extraprovincial syndicated loan agreements 9.2(1) In this section, Canadian corporation means a corporation (a) incorporated or continued in a jurisdiction in Canada, outside of Alberta, and (b) whose head office is outside of Alberta. (2) Subject to subsection (3), Alberta Treasury Branches may enter into a syndicated loan agreement with one or more financial institutions in respect of a Canadian corporation if the corporation operates in Alberta. (3) Alberta Treasury Branches s participation in syndicated loan agreements under subsection (2) must not exceed in the aggregate 10% of the total amount of commercial loans made by Alberta Treasury Branches at any one time. 7 Section 10 is amended (a) in subsection (1) (i) by adding derivative contracts, including after into ;

32 ALTA. REG. 164/2002 ALBERTA TREASURY BRANCHES (ii) by striking out or rate and substituting and rate ; (b) by repealing subsection (2) and substituting the following: (2) Alberta Treasury Branches may enter into a transaction listed in subsection (1) with an existing customer of Alberta Treasury Branches only where (a) the purpose of the transaction is to hedge against risks of the customer relating to interest rates, commodity prices or exchange rates, and (b) if the purpose of the transaction is to hedge against risks of the customer relating to commodity prices, Alberta Treasury Branches takes an opposite position in the market to offset the risk it assumes under the transaction. (c) by adding the following after subsection (2.1): (2.2) Alberta Treasury Branches may, for asset-liability management purposes, negotiate the replacing or unwinding of existing derivative contracts. (2.3) Alberta Treasury Branches may enter into credit derivative contracts with financial institutions in Canada that have at least one of the credit ratings referred to in the table in subsection (3) in respect of residential mortgage loans made under section 9 for the purpose of diversifying its geographic concentration risk. (d) in subsection (3) (i) by striking out a rating in accordance with and substituting at least one of the ratings referred to in ; (ii) by repealing the table and substituting the following: Table of Securities Ratings Rating Organization Long-term Rating Short-term Rating Standard and Poor s AA- A-1(High) Moody s Investors Service Aa3 P-1 Dominion Bond Rating Service AA(Low) R-1(Mid) 8 Section 11 is amended by adding the following after subsection (4): (5) Notwithstanding subsection (1), once Alberta Treasury Branches becomes fully capitalized in the opinion of the Minister, the base fee with respect to a particular fiscal year is

33 ALTA. REG. 164/2002 ALBERTA TREASURY BRANCHES (a) in the case of deposits not greater than $60 000, the lesser of (i) an amount equal to the total of those deposits held by Alberta Treasury Branches at the end of the fiscal year, as shown in Alberta Treasury Branches audited financial statements, multiplied by Canada Deposit Insurance Corporation s rate for a deposit-taking institution with a similar risk profile as Alberta Treasury Branches, as determined by the Minister, and (ii) an amount equal to 1/6 of 1% of all those deposits held by Alberta Treasury Branches at the end of the fiscal year, as shown in Alberta Treasury Branches audited financial statements; (b) in the case of deposits greater than $60 000, an amount equal to 1/6 of 1% of all those deposits held by Alberta Treasury Branches at the end of the fiscal year, as shown in Alberta Treasury Branches audited financial statements. (6) For the purposes of applying the rates in subsection (5), the Minister may accept an estimate prepared by Alberta Treasury Branches of the amount of deposits greater than $ if that amount is not reported in Alberta Treasury Branches audited financial statements. 9 The following is added after section 23: Compliance with guidelines 23.1(1) The board shall establish guidelines, satisfactory to the Minister, related to investments, lending and capital adequacy. (2) Alberta Treasury Branches shall provide to the Minister annually on or before the date on which it submits its annual financial statements to the Minister under section 23 of the Act, an audited report on its compliance with the guidelines referred to in subsection (1), in the form prescribed by the Minister. 10 Section 29 is repealed and the following is substituted: Liquidity investments 29 Alberta Treasury Branches shall have and keep available unencumbered liquid assets in accordance with the guidelines referred to in section Section 30 is amended (a) in subsection (2) by striking out 5 years and substituting 15 years ;

34 ALTA. REG. 165/2002 FINANCIAL CONSUMERS (b) by adding the following after subsection (2): (3) For the purposes of subsection (2), retain includes the conversion of a guarantee, given by Alberta Treasury Branches, into a loan Alberta Regulation 165/2002 Financial Consumers Act FINANCIAL CONSUMERS REGULATION Filed: July 23, 2002 Made by the Lieutenant Governor in Council (O.C. 361/2002) on July 23, 2002 pursuant to section 49 of the Financial Consumers Act. Table of Contents Definitions 1 Exempt named financial products 2 Exempt agents 3 Repeal 4 Expiry 5 Definition 1(1) In this Regulation, Act means the Financial Consumers Act. (2) For the purposes of the Act, securities dealer means a person who is registered as a dealer under the Securities Act. Exempt named financial products 2 The following are not named financial products for the purposes of section 2(i) of the Act: (a) a contract of group insurance, as defined in the Insurance Act, or any certificate issued under such a contract; (b) a contract of creditor s group insurance, as defined in the Insurance Act, or any certificate issued under such a contract; (c) a pension plan, as defined in the Employment Pension Plans Act, or any interest in such a plan; (d) life insurance contracts that are exempt policies for the purposes of the Income Tax Act (Canada)

35 Exempt agents 3 Section 17 of the Act does not apply to the following: (a) an agent who is or is employed by a member of (i) the Investment Dealers Association of Canada, (ii) the Canadian Venture Exchange Inc., (iii) Bourse de Montreal Inc., or (iv) the Toronto Stock Exchange Inc.; (b) an agent who is authorized in writing to issue a receipt in the name of a supplier for which the supplier will accept responsibility; (c) an agent who is registered to sell mutual funds under the Securities Act. Repeal 4 The Financial Consumers Regulation (AR 102/91) is repealed. Expiry 5 For the purpose of ensuring that this Regulation is reviewed for ongoing relevancy and necessity, with the option that it may be repassed in its present or an amended form following a review, this Regulation expires on June 30, Alberta Regulation 166/2002 Government Organization Act COMMUNITY DEVELOPMENT GRANTS AMENDMENT REGULATION Filed: July 23, 2002 Made by the Lieutenant Governor in Council (O.C. 362/2002) on July 23, 2002 pursuant to section 16 of the Government Organization Act. 1 The Community Development Grants Regulation (AR 57/98) is amended by this Regulation. 2 Schedule 3 is repealed and the following is substituted: SCHEDULE 3 COMMUNITY INITIATIVES PROGRAM GRANTS 1 The Minister may make grants under this Schedule to enhance and enrich project-based community initiatives in community services, parks, libraries, education, children s services, the environment, recreation and sport, arts and culture, health, social services or seniors services

36 ALTA. REG. 166/2002 GOVERNMENT ORGANIZATION 2(1) An application for a grant under this Schedule must be submitted to the Minister and be in a form specified by the Minister. (2) In addition to meeting the requirements of section 5 of this Regulation, an applicant must also provide any additional information required by the Minister. 3 The Minister may, after receiving an application, make a grant under this Schedule to the applicant in an amount and on any conditions that the Minister considers appropriate or may refuse the application. 4 An applicant is not eligible for more than one grant under this Schedule in respect of the same project in the same fiscal year. 5(1) A grant under this Schedule may be held unspent by the recipient of the grant for a period of not more than 2 years from the date of issuance of the grant payment, unless otherwise agreed to by the Minister. (2) A grant under this Schedule is to be accounted for separately in the recipient s books and accounts and in the recipient s statement of revenues and expenditures. (3) Any interest that accrues to a grant under this Schedule is to be treated as part of the grant and must be used for the same purpose by the grant recipient Alberta Regulation 167/2002 Persons with Development Disabilities Community Governance Act Financial Administration Act MICHENER CENTRE FACILITY BOARD TRANSFER OF GOVERNANCE REGULATION Filed: July 23, 2002 Made by the Lieutenant Governor in Council (O.C. 363/2002) on July 23, 2002 pursuant to section 23 of the Persons with Developmental Disabilities Community Governance Act and section 80 of the Financial Administration Act. Definition 1 In this Regulation, Board means the Michener Centre Facility Board

37 ALTA. REG. 166/2002 GOVERNMENT ORGANIZATION Approval to wind up 2 The Lieutenant Governor in Council approves the winding up of the Board. Winding up 3 The activities of the Board are wound up and the activities are assumed by the Central Region Community Board. Transfer of assets and liabilities 4 The following applies: (a) the property and assets of the Board are the property and assets of the Central Region Community Board; (b) the Central Region Community Board is liable for the obligations and liabilities of the Board; (c) an existing cause of action, claim or liability to prosecution of, by or against the Board is unaffected and may be continued by or against the Central Region Community Board; (d) a civil, criminal or administrative action or proceeding pending by or against the Board may be continued by or against the Central Region Community Board; (e) a conviction against, or ruling, order or judgment in favour of or against the Board may be enforced by or against the Central Region Community Board